HLX-22
目录号 : KM35811 CAS No. : 2851060-90-5 纯度 : 99%
HLX-22 是一种靶向 HER2 的人源化单克隆抗体。HLX-22 与曲妥珠单抗 联合使用可诱导 HER2 过表达的乳腺癌和胃癌细胞凋亡 (apoptosis)。HLX-22 对晚期实体瘤具有强效的抗肿瘤活性。
规格 价格 是否有货 数量
1mg
In-stock
5mg 询价 In-stock
10mg 询价 In-stock
50mg 询价 In-stock
100mg 询价 In-stock

Other Forms of Rapamycin:

KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
生物活性
HLX-22 is a humanized monoclonal antibody targeting HER2. HLX-22 induces apoptosis in HER2-overexpressing breast and gastric cancer cells combined with Trastuzumab . HLX-22 has potent antitumor activity against advanced solid tumors.
CAS号
2851060-90-5
运输条件
Shipping with dry ice.
储存方式
Powder -20°C 3 years
  4°C 2 years
In solvent -80°C 6 months
  -20°C 1 month
暂无相关参考文献
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2